Login

Mr Karolis Rosickas, CEO, Regeneus Ltd 00:00:00

Share On Facebook Share On Twitter

Karolis was appointed CEO of Regeneus on 2 November 2020.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
2024 Midyear Outlook: Waves of Transformation | BlackRock Bottom Line
00:10:00
Embracing the AI Revolution: Insights from Raj Shant, Managing Director at Jennison Associates,
00:10:00
The Accelerating Impact of Technology in Financial Services | Piyush Gupta , CEO,  DBS Bank .
00:10:00
David Stein Discusses Investing in Junior Mining and Kuya Silver's Strategy
00:10:00
M1 Finance's New $3 Fee: What Are Your Options?
00:10:00
Central Bank Actions and Market Impacts: Fed, BoE, ECB, and Commodities
00:10:00
A Discussion on Decentralization and Renewable Technologies | Louis Maurice, CEO, Groupe Okwind SA.
00:10:00
A Discussion on an Industrial Plan's Impact on Energy Transition and Community Development | Stefano Cetti , CEO, Acinque SpA.
00:10:00
Female Founders are shaping China's Innovation Landscape with|Xu Ying,General Partner,Vertex Ventures
00:10:00
Jericho Go Discusses Megaworld's Continued Confidence in Office and Retail Sectors | Jericho Go, CEO, RL Commercial REIT.
00:10:00
Perion Network CEO Tal Jacobson joins Nicole Petallides to discuss the company's role in major digital advertising channels.
00:10:00
Challenges and Opportunities in Electric Mobility and Circular Economy: Insights from a Speech | Renato Mazzoncini , CEO, A2A Spa.

© 2026 Nehu